Pilot Trial of Memantine in the Treatment of Posttraumatic Stress Disorder
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
This multiple case series was initially designed as a prospective, open-label, 12-week trial investigation evaluating memantine (Namenda) for the treatment of psychiatric and cognitive symptoms associated with PTSD. In a selected, small sample of individuals (n = 4) with combat PTSD, treatment with memantine produced consistent improvement on a delayed recall measure of memory, variable reduction of depressive symptoms, and variable reduction in hyperarousal symptoms. These data suggest potential positive treatment outcomes, both cognitively and psychiatrically, and provide rationale for future double-blind, placebo-controlled studies of memantine in PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Data from the Addiction Severity Index Reliability and Validity in Three Centers
McLELLAN, A. T., LUBORSKY, L., CACCIOLA, J., GRIFFITH, J., EVANS, F., BARR, H. L., & OʼBRIEN, C. P. (1985) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198507000-00005 · Cited by 1,503 · cited 1×
“The diagnostic interview included a variety of structured ratings including the Structured Clinical Interview for DSM–IV, Non–Patient edition (SCIDS NP; Spitzer, Williams, Gibbon, & First, 1992), the Addiction Severity Index (ASI, McLellan, 1985), and the CAPS which was mentioned above.”
MethodVermetten, E., Vythilingam, M., Southwick, S. M., Charney, D. S., & Bremner, J. D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00634-6 · Cited by 487
Wilcock, G., M??bius, H. J., & St??ffler, A. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200211000-00005 · Cited by 381
Bremner, J. D., Vythilingam, M., Vermetten, E., Southwick, S. M., McGlashan, T., Staib, L. H., Soufer, R., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01891-7 · Cited by 299 · cited 1×
“In addition to intense and often debilitating psychological symptoms, cognitive deficits in attention, memory and learning have been documented in numerous research studies (Bremner et al., 2003; Horner & Hamner, 2002; Vasterling et al., 2002; Vasterling et al., 1998).”
BackgroundAdamec, R. E., Burton, P., Shallow, T., & Budgell, J. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00226-1 · Cited by 171
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Other therapies: Small, open case series have suggested benefits with trazodone [1053], buspirone [1051,1052], and memantine [1054] (all Level 4).”
BackgroundBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., et al. (2012) · CNS Drugs · doi:10.2165/11634390-000000000-00000 · Cited by 273
New perspectives in glutamate and anxiety
Riaza Bermudo-Soriano, C., Perez-Rodriguez, M. M., Vaquero-Lorenzo, C., & Baca-Garcia, E. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.010 · Cited by 207
Grossberg, G., & Thomas, S. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s6666 · Cited by 151
“A pilot study examined memantine as a treatment for patients suffering from combat-related post-traumatic stress disorder (PTSD).(65) Four patients were treated with memantine and evaluated for immediate memory, delayed memory, hyperarousal, and depression.”
Metadata
- Authors
- Battista, M. A., Hierholzer, R., Khouzam, H. R., Barlow, A., & O'Toole, S.
- Venue
- Psychiatry: Interpersonal and Biological Processes
- Publisher
- Guilford Publications
- Published
- 2007-06
- Volume
- 70
- Issue
- 2
- Pages
- 167-174
- ISSN
- 0033-2747 (ISSN-L)
- OpenAlex
- W2042967783
- Cited by
- 47
- References
- 5
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pilot Trial of Memantine in the Treatment of Posttraumatic Stress Disorder. https://app.cochat.ai/papers/10.1521/psyc.2007.70.2.167
- The paper
- Battista, M. A., Hierholzer, R., Khouzam, H. R., Barlow, A., & O'Toole, S. (2007). Pilot Trial of Memantine in the Treatment of Posttraumatic Stress Disorder. Psychiatry: Interpersonal and Biological Processes. https://doi.org/10.1521/psyc.2007.70.2.167
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.